Abner Herrman & Brock’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Abner Herrman & Brock's LLY Position: Q2 2026 in Review
Abner Herrman & Brock increased its Eli Lilly (LLY) stake by 1.1% in Q2 2026, buying an estimated $307K and bringing the position to 27,138 shares worth $32.5M. The position accounts for 3.09% of the portfolio, ranked #9.
Abner Herrman & Brock first reported a position in LLY in Q3 2016 and has held it in 18 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Abner Herrman & Brock held 27,138 shares of Eli Lilly worth $32.5M as of Q2 2026.
- Abner Herrman & Brock bought 300 Eli Lilly shares in Q2 2026, an estimated $307K.
- Eli Lilly made up 3.09% of Abner Herrman & Brock's portfolio in Q2 2026, its #9 holding.
- Abner Herrman & Brock first reported a position in Eli Lilly in Q3 2016 and has held it in 18 quarters since.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Abner Herrman & Brock's 13F filing for Q2 2026, filed 8 Jul 2026.